Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + levofloxacin-based once-daily quadruple therapy for Helicobacter pylori infection in high clarithromycin resistance area
TCTR20240809001Phase 3Completed
- Sponsor
- Thailand Science Research and Innovation
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Thailand Science Research and Innovation. Started Nov 2022; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20240809001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240809001.